1. |
Luo J, Wang R, Han B, et al. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stageⅠlung adenocarcinoma. Oncotarget, 2017, 8(4): 7050-7058.
|
2. |
Choi SH, Jeong JY, Lee SY, et al. Clinical implication of minimal presence of solid or micropapillary subtype in early-stage lung adenocarcinoma. Thorac Cancer, 2021, 12(2): 235-244.
|
3. |
Chen T, Luo J, Gu H, et al. Impact of solid minor histologic subtype in postsurgical prognosis of stageⅠlung adenocarcinoma. Ann Thorac Surg, 2018, 105(1): 302-308.
|
4. |
Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: The bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol, 2017, 14(12): 749-762.
|
5. |
Wilson R, Devaraj A. Radiomics of pulmonary nodules and lung cancer. Transl Lung Cancer Res, 2017, 6(1): 86-91.
|
6. |
He B, Song Y, Wang L, et al. A machine learning-based prediction of the micropapillary/solid growth pattern in invasive lung adenocarcinoma with radiomics. Transl Lung Cancer Res, 2021, 10(2): 955-964.
|
7. |
Chen LW, Yang SM, Wang HJ, et al. Prediction of micropapillary and solid pattern in lung adenocarcinoma using radiomic values extracted from near-pure histopathological subtypes. Eur Radiol, 2021, 31(7): 5127-5138.
|
8. |
Park S, Lee SM, Noh HN, et al. Differentiation of predominant subtypes of lung adenocarcinoma using a quantitative radiomics approach on CT. Eur Radiol, 2020, 30(9): 4883-4892.
|
9. |
Chen LW, Yang SM, Chuang CC, et al. Solid attenuation components attention deep learning model to predict micropapillary and solid patterns in lung adenocarcinomas on computed tomography. Ann Surg Oncol, 2022, 29(12): 7473-7482.
|
10. |
Hattori A, Matsunaga T, Takamochi K, et al. Surgical resection for clinical-stageⅠradiological pure-solid lung cancer that met the current high risk criteria. Jpn J Clin Oncol, 2017, 47(7): 630-638.
|
11. |
Hattori A, Suzuki K, Takamochi K, et al. Prognostic impact of a ground-glass opacity component in clinical stage ⅠA non-small cell lung cancer. J Thorac Cardiovasc Surg, 2021, 161(4): 1469-1480.
|
12. |
Lefebvre TL, Ueno Y, Dohan A, et al. Development and validation of multiparametric MRI-based radiomics models for preoperative risk stratification of endometrial cancer. Radiology, 2022, 305(2): 375-386.
|
13. |
Perez-Johnston R, Araujo-Filho JA, Connolly JG, et al. CT-based radiogenomic analysis of clinical stageⅠlung adenocarcinoma with histopathologic features and oncologic outcomes. Radiology, 2022, 303(3): 664-672.
|
14. |
van Timmeren JE, Cester D, Tanadini-Lang S, et al. Radiomics in medical imaging: "How-to" guide and critical reflection. Insights Imaging, 2020, 11(1): 91.
|
15. |
Wang T, She Y, Yang Y, et al. Radiomics for survival risk stratification of clinical and pathologic stageⅠA pure-solid non-small cell lung cancer. Radiology, 2022, 302(2): 425-434.
|
16. |
Meng X, Gao D, Jin H, et al. Factors affecting volume reduction velocity for arteriovenous malformations after treatment with dose-stage stereotactic radiosurgery. Front Oncol, 2021, 11: 769533.
|